Coronado Biosciences, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses
Research and Development 25,682 17,468 8,583 8,341
Sales, General and Admin. 10,098 8,665 5,755 900
Non-Recurring Items - 1,043 20,706 -
Other - - - -
Operating Income (35,780) (27,176) (35,044) (9,241)
Income From Continuing Operations
Add'l Income/Expense Items 545 236 (1,242) 794
Earnings Before Interest and Tax (35,235) (26,940) (36,286) (8,447)
Interest Expense 1,923 670 74 1,535
Earnings Before Tax (37,158) (27,610) (36,360) (9,982)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (37,158) (27,610) (36,360) (9,982)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (37,158) (27,610) (36,360) (9,982)
Preferred Stock and Other Adjustments - - (5,861) -
Net Income Applicable to Common Shareholders (37,158) (27,610) (42,221) (9,982)